|
|
|
|
|
|
|
|
|
|
Epithelial Ovarian Cancer Clinical Trial:
Brief Summary
Official Title: “A
Randomized Controlled Trial Using Novel Markers to Predict Malignancy in
Elevated-Risk Women”
Condition Keyword(s):
Intervention(s):
The Novel Markers Trial will compare the safety, feasibility
and effectiveness of two different epithelial ovarian cancer screening
strategies that use CA125 and add HE4 as either a first or second line
screen. This study is the next step in a larger research effort to
develop a blood test that can be used as a screening method for the
early detection of epithelial ovarian cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.